MD3675894T2 - Compoziție pentru stimularea ovariană controlată - Google Patents

Compoziție pentru stimularea ovariană controlată

Info

Publication number
MD3675894T2
MD3675894T2 MDE20200700T MDE20200700T MD3675894T2 MD 3675894 T2 MD3675894 T2 MD 3675894T2 MD E20200700 T MDE20200700 T MD E20200700T MD E20200700 T MDE20200700 T MD E20200700T MD 3675894 T2 MD3675894 T2 MD 3675894T2
Authority
MD
Moldova
Prior art keywords
composition
ovarian stimulation
controlled ovarian
fsh
controlled
Prior art date
Application number
MDE20200700T
Other languages
English (en)
Inventor
Saez Joan-Carles Arce
Lisbeth Helmgaard
Bjarke Mirner Klein
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MD3675894T2 publication Critical patent/MD3675894T2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Preparate care includ FSH, de exemplu FSH recombinat, pentru utilizare în tratamentul infertilităţii la pacienţii cu nivel AMH ridicat şi greutate corporală scăzută.
MDE20200700T 2017-09-01 2018-08-31 Compoziție pentru stimularea ovariană controlată MD3675894T2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17189119 2017-09-01
PCT/EP2018/073442 WO2019043143A1 (en) 2017-09-01 2018-08-31 COMPOSITION FOR CONTROLLED OVARIAN STIMULATION

Publications (1)

Publication Number Publication Date
MD3675894T2 true MD3675894T2 (ro) 2022-03-31

Family

ID=59772482

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20200700T MD3675894T2 (ro) 2017-09-01 2018-08-31 Compoziție pentru stimularea ovariană controlată

Country Status (31)

Country Link
US (2) US11744879B2 (ro)
EP (3) EP4427806A3 (ro)
JP (2) JP6856819B2 (ro)
KR (1) KR20200045543A (ro)
CN (1) CN111050787A (ro)
AR (1) AR112541A1 (ro)
AU (1) AU2018326556B2 (ro)
BR (1) BR112020003379A2 (ro)
CA (1) CA3073624A1 (ro)
CL (1) CL2020000482A1 (ro)
DK (2) DK3675894T3 (ro)
EA (1) EA202090480A1 (ro)
ES (1) ES2904787T3 (ro)
FI (1) FI3973982T3 (ro)
HR (1) HRP20211802T1 (ro)
HU (1) HUE056726T2 (ro)
IL (1) IL272763B2 (ro)
JO (1) JOP20200034A1 (ro)
LT (2) LT3973982T (ro)
MA (2) MA50034B1 (ro)
MD (1) MD3675894T2 (ro)
MX (2) MX2020002235A (ro)
PH (1) PH12020500404A1 (ro)
PL (1) PL3675894T3 (ro)
PT (2) PT3973982T (ro)
RS (1) RS62810B1 (ro)
SG (1) SG11202003840QA (ro)
SI (1) SI3675894T1 (ro)
TW (1) TWI749255B (ro)
UA (1) UA126869C2 (ro)
WO (1) WO2019043143A1 (ro)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202237173A (zh) * 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS50805B (sr) * 2000-01-27 2010-08-31 Laboratoires Serono Sa. Upotreba fsh za lečenje neplodnosti
US20040248784A1 (en) 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
WO2009036771A1 (es) * 2007-09-21 2009-03-26 Pharmabrand S.A. Composición de polisacáridos mucilaginosos, derivados de aloe barbadensis, en combinación con liposomas, procedimiento de obtención y uso de la misma como fotoprotectora, antiacné, regeneradora de la epidermis e hidratante
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
EP2526111A2 (en) * 2010-01-21 2012-11-28 Ramot at Tel Aviv University, Ltd. Aloe-emodin derivatives and use thereof for the treatment of cancer
SI2621517T2 (sl) 2010-09-29 2023-11-30 Ferring B.V. Sestavek za uporabo pri zdravljenju neplodnosti
WO2012168680A1 (en) 2011-06-06 2012-12-13 Ferring B.V. Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
SG11201608132UA (en) * 2014-04-18 2016-11-29 Glycotope Gmbh Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone
DK3261661T3 (da) 2015-02-26 2024-01-15 Ferring Bv Menotropin til behandling af infertilitet
DK3283097T3 (da) 2015-04-17 2020-04-20 Ferring Bv Fsh til behandling af infertilitet
RS61163B1 (sr) 2015-04-24 2021-01-29 Ferring Bv Postupak proizvodnje gonadotrofina
WO2016207353A1 (en) 2015-06-26 2016-12-29 Ferring B.V. Methods of purification and/or viral inactivation
JP2021522268A (ja) 2018-04-30 2021-08-30 フェリング ベスローテン フェンノートシャップ 制御された卵巣刺激のための組成物
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法

Also Published As

Publication number Publication date
DK3675894T3 (da) 2022-01-24
AU2018326556A1 (en) 2020-03-05
RS62810B1 (sr) 2022-02-28
EP3973982A1 (en) 2022-03-30
EP4427806A3 (en) 2024-10-09
US11744879B2 (en) 2023-09-05
SI3675894T1 (sl) 2022-01-31
IL272763A (en) 2020-04-30
CA3073624A1 (en) 2019-03-07
LT3973982T (lt) 2024-09-10
SG11202003840QA (en) 2020-05-28
ES2904787T3 (es) 2022-04-06
HUE056726T2 (hu) 2022-03-28
IL272763B1 (en) 2023-10-01
AU2018326556B2 (en) 2024-09-26
CL2020000482A1 (es) 2020-06-26
AR112541A1 (es) 2019-11-06
MA56224A (fr) 2022-04-20
CN111050787A (zh) 2020-04-21
BR112020003379A2 (pt) 2020-08-25
KR20200045543A (ko) 2020-05-04
JP7373479B2 (ja) 2023-11-02
US20240024424A1 (en) 2024-01-25
LT3675894T (lt) 2021-12-10
PL3675894T3 (pl) 2022-02-21
EP3675894A1 (en) 2020-07-08
MA50034B1 (fr) 2022-02-28
TWI749255B (zh) 2021-12-11
PT3675894T (pt) 2022-01-25
JP2020528071A (ja) 2020-09-17
JOP20200034A1 (ar) 2020-02-13
WO2019043143A1 (en) 2019-03-07
MX2024009224A (es) 2024-08-06
JP2021046398A (ja) 2021-03-25
EP3675894B1 (en) 2021-11-03
IL272763B2 (en) 2024-02-01
EP3973982B1 (en) 2024-07-31
JP6856819B2 (ja) 2021-04-14
HRP20211802T1 (hr) 2022-03-04
MX2020002235A (es) 2020-07-20
FI3973982T3 (fi) 2024-09-23
MA50034A (fr) 2021-05-12
US20200197493A1 (en) 2020-06-25
DK3973982T3 (da) 2024-09-23
EA202090480A1 (ru) 2020-07-20
UA126869C2 (uk) 2023-02-15
PH12020500404A1 (en) 2021-03-01
PT3973982T (pt) 2024-09-16
TW201919687A (zh) 2019-06-01
EP4427806A2 (en) 2024-09-11

Similar Documents

Publication Publication Date Title
MX2023014569A (es) Anticuerpos anti-sirpa.
CR20190376A (es) Formulaciones de anticuerpos de her2 subcutáneas
MY169165A (en) Anti-pdgfr-beta antibodies and uses thereof
NZ745186A (en) 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
NZ745188A (en) 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2018008640A (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano.
MX2022002635A (es) Anticuerpos anti proteina similar a angiopoyetina 4 y metodos de uso.
PH12020550942A1 (en) Antimicrobial peptides and methods of using same
MX2017010883A (es) Composicion para el tratamiento de la infertilidad.
PH12021550122A1 (en) Solubilized apyrases, methods and use
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
PH12020500029A1 (en) Cosmetic compositions and methods of use
MX2018009499A (es) Anticuerpos monoclonales especificos de egfl6 y metodos de su uso.
MX2018008643A (es) Derivados de 3-((hetero)aril)-8-amino-2-oxo-1,3-diaza-espiro-[4.5] -decano.
MX2020000636A (es) Proteinas sinteticas y usos terapeuticos de las mismas.
MD3675894T2 (ro) Compoziție pentru stimularea ovariană controlată
PH12021550417A1 (en) Compositions and methods for controlled ovarian stimulation
EA202190891A1 (ru) Композиции и способы для контролируемой стимуляции яичников
NZ734845A (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
MY173606A (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease